GPR119
GPR119 is G-protein-coupled receptor for lipid amides OEA (oleoylethanolamide) and LPC (lysophosphatidylcholine). It may function in glucose homeostasis and insulin secretion. Act as a potential therapeutic target for type 2 diabetes.
Products Related to GPR119(10)
- GC13294PSN 375963 hydrochlorideCAS: 388575-52-8Purity: >98.00%
PSN 375963 hydrochloride is a potent GPR119 agonist, with EC50s of 8.4 and 7.9 μM for human and mouse GPR119, respectively.
- GC31508FiruglipelCAS: 1371591-51-3Purity: >99.00%
Firuglipel (DS-8500a) is an orally available, potent and selective GPR119 agonist.
- GC404062-Oleoyl GlycerolCAS: 3443-84-3Purity: >98.00%
2-Oleoyl glycerol (2-OG) is a natural monoacylglycerol with an 18:1 oleoyl group at the sn-2 position of glycerol.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11434 | GSK1292263 | 1032823-75-8 | >99.00% | |
Novel GPR119 agonist | ||||
| GC12018 | AS 1269574 | 330981-72-1 | >98.50% | |
GPR119 receptor agonist | ||||
| GC12514 | MBX-2982 | 1037792-44-1 | >99.50% | |
An agonist of GPR119 | ||||
| GC13294 | PSN 375963 hydrochloride | 388575-52-8 | >98.00% | |
PSN 375963 hydrochloride is a potent GPR119 agonist, with EC50s of 8.4 and 7.9 μM for human and mouse GPR119, respectively. | ||||
| GC14944 | AR 231453 | 733750-99-7 | >99.50% | |
GPR119 agonist,potent and selective | ||||
| GC19033 | APD597 | 897732-93-3 | >99.50% | |
APD597 is a GPR119 agonist intended for the treatment of type 2 diabetes, with EC50 of 46 nM for hGPR119. | ||||
| GC31508 | Firuglipel | 1371591-51-3 | >99.00% | |
Firuglipel (DS-8500a) is an orally available, potent and selective GPR119 agonist. | ||||
| GC40406 | 2-Oleoyl Glycerol | 3443-84-3 | >98.00% | |
2-Oleoyl glycerol (2-OG) is a natural monoacylglycerol with an 18:1 oleoyl group at the sn-2 position of glycerol. | ||||
| GC10365 | PSN632408 | 857652-30-3 | >99.50% | |
Human and mouse GPR119 agonist | ||||
| GC12738 | APD668 | 832714-46-2 | >99.50% | |
Potent GPR119 agonist | ||||
